Annals of Hematology

, Volume 86, Issue 10, pp 763–765 | Cite as

Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia

  • Sebastian Scholl
  • Joachim Lüftner
  • Lars-Olof Mügge
  • Volker Schmidt
  • Hans-Jörg Fricke
  • Klaus Höffken
Letter to the Editor

References

  1. 1.
    Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352:254–266PubMedCrossRefGoogle Scholar
  2. 2.
    Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF et al (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106:3733–3739PubMedCrossRefGoogle Scholar
  3. 3.
    Boissel N, Renneville A, Biggio V, Philippe N, Thomas X, Cayuela JM et al (2005) Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype. Blood 106:3618–3620PubMedCrossRefGoogle Scholar
  4. 4.
    Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W et al (2005) Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 106:3747–3754PubMedCrossRefGoogle Scholar
  5. 5.
    Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A et al (2005) Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 106:3740–3746PubMedCrossRefGoogle Scholar
  6. 6.
    Suzuki T, Kiyoi H, Ozeki K, Tomita A, Yamaji S, Suzuki R et al (2005) Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood 106:2854–2861PubMedCrossRefGoogle Scholar
  7. 7.
    Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY, Wu SJ et al (2006) Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res 66:3310–3316PubMedCrossRefGoogle Scholar
  8. 8.
    Rappaport H (1966) Tumors of the hematopoietic system: In: Atlas of tumor pathology, section 3, fascicle 8. Armed Forces Institute of Pathology, Washington, DC, pp 241–243Google Scholar
  9. 9.
    Swirski DM, Li YS, Matthews JG, Flemans RJ, Rees JK, Hayhoe FG (1984) 8;21 Translocation in acute granulocyte leukaemia: cytological, cytochemical and clinical features. Br J Haematol 56:199–213Google Scholar
  10. 10.
    Bolli N, Galimberti S, Martelli MP, Tabarrini A, Roti G, Mecucci C et al (2006) Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia. Lancet Oncol 7:350–352PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Sebastian Scholl
    • 1
  • Joachim Lüftner
    • 2
  • Lars-Olof Mügge
    • 1
  • Volker Schmidt
    • 1
  • Hans-Jörg Fricke
    • 1
  • Klaus Höffken
    • 1
  1. 1.Department of Internal Medicine II (Oncology/Hematology/Gastroenterology/Infectious Disease)Medical Faculty at Friedrich Schiller UniversityJenaGermany
  2. 2.Institute of PathologyMeiningenGermany

Personalised recommendations